The novel mechanism of recombinant human ciliary neurotrophic factor on the anti-diabetes activity

Basic and Clinical Pharmacology and Toxicology

Volumn 101, Issue 2, 2007, Pages 78-84

  Liu, Qing Shan ^b   Gao, Mei ^a   Zhu, Shen Yin ^a,c   Li, Shao Jing ^a   Zhang, Li ^a   Wang, Qiu Juan ^b   Du, Guan Hua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CILIARY NEUROTROPHIC FACTOR; FATTY ACID; GENE PRODUCT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR COACTIVATOR 1 ALPHA; RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; FEMALE; GENE EXPRESSION; LIPID STORAGE; MALE; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; UPREGULATION; WEIGHT REDUCTION;

ADIPOSE TISSUE, BROWN; ANIMALS; CILIARY NEUROTROPHIC FACTOR; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MICE; MICE, OBESE; PPAR ALPHA; RECOMBINANT PROTEINS;

MUS;

EID: 34447641485     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2007.00092.x     Document Type: Article

References (29)

1. Unger RH. Lipotoxic diseases. Annu Rev Med 2002 53 : 319 36.
2. Watt JA, Bone S, Pressler M, Cranston HJ, Paden CM. Ciliary neurotrophic factor is expressed in the magnocellular neurosecretory system of the rat in vivo: evidence for injury- and activity-induced up-regulation. Exp Neurol 2006 197 : 206 14.
3. Kelleher MO, Myles LM, Al-Abri RK, Glasby MA. The use of ciliary neurotrophic factor to promote recovery after peripheral nerve injury by delivering it at the site of the cell body. Acta Neurochir (Wien) 2006 148 : 55 61.
4. Zvonic S, Baugh J, Arbour-Reily P, Mynatt RL, Stephens JM. Cross-talk among gp130 cytokines in adipocytes. J Biol Chem 2005 280 : 33856 63.
5. Unger RH, Zhou YT. Lipotoxicity of β-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001 50 : S118 21.
6. Winzell MS, Svensson H, Enerback S et al. Pancreatic β-cell lipotoxicity induced by overexpression of hormone-sensitive lipase. Diabetes 2003 52 : 2057 65.
7. Watt MJ, Hevener A, Lancaster GI, Febbraio MA. Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating ceramide accumulation and phosphorylation of c-Jun N-terminal kinase in peripheral tissues. Endocrinology 2006 147 : 2077 85.
8. Bluher S, Moschos S, Bulen J et al. Ciliary neurotrophic factorAx15 alters energy homeostasis, decreases body weight, and improves metabolic control in diet-induced obese and UCP1-DTA mice. Diabetes 2004 53 : 2787 96.
9. Ishigaki Y, Katagiri T, Yamada T et al. Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity. Diabetes 2005 54 : 322 32.
10. Mracek T, Jesina P, Krivakova P et al. Time-course of hormonal induction of mitochondrial glycerophosphate dehydrogenase biogenesis in rat liver. Biochim Biophys Acta 2005 1726 : 217 23.
11. Zhang B, He XL, Ding Y, Du GH. Gaultherin, a natural salicylate derivative from Gaultheria yunnanensis: towards a better non-steroidal anti-inflammatory drug. Eur J Pharmacol 2006 530 : 166 71.
12. Du G, Willet K, Mouithys-Mickalad A, Sluse-Goffart CM, Droy-Lefaix MT, Sluse FE. EGb 761 protects liver mitochondria against injury induced by in vitro anoxia/reoxygenation. Free Radic Biol Med 1999 27 : 596 604.
13. Li LX, MacDonald PE, Ahn DS, Oudit GY, Backx PH, Brubaker PL. Role of phosphatidylinositol 3-kinaseγ (PI3-Kγ) in the β-cell: interactions with glucagon-like peptide-1. Endocrinology 2006 147 : 3318 25.
14. Eto K, Tsubamoto Y, Terauchi Y et al. Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 1999 : 283 : 981 5.
15. Matsui J, Terauchi Y, Kubota N et al. Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-γ-deficient mice on a high-fat diet. Diabetes 2004 53 : 2844 54.
16. Chaldakov GN, Fiore M, Hristova MG, Aloe L. Metabotrophic potential of neurotrophins: implication in obesity and related diseases? Med Sci Monit 2003 9 : HY19 21.
17. Russell LK, Mansfield CM, Lehman JJ, Kovacs A, Courtois M, Saffitz JE. Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-actived receptor γ coactivator-1α promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res 2004 94 : 525 33.
18. Pan DA, Lillioja S, Kriketos AD et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997 46 : 983 8.
19. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-α. Diabetes 2002 51 : 2005 11.
20. Yu C, Chen Y, Cline GW et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002 277 : 50230 6.
21. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 2002 32 (Suppl 3 14 23.
22. Andersson U, Scarpulla RC. PGC-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol Cell Biol 2001 21 : 3738 49.
23. Franco MC, Arciuch VG, Peralta JG et al. Hypothyroid phenotype is contributed by mitochondrial complex I inactivation due to translocated neuronal nitric-oxide synthase. J Biol Chem 2006 281 : 4779 86.
24. Gleyzer N, Vercauteren K, Scarpulla RC. Control of mitochondrial transcription specificity factors (TFB1 M and TFB2 M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Mol Cell Biol 2005 25 : 1354 66.
25. Baar K, Song Z, Semenkovich CF et al. Skeletal muscle overexpression of nuclear respiratory factor 1 increases glucose transport capacity. FASEB J 2003 17 : 1666 73.
26. Bergeron R, Yao J, Woods JW et al. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in ZDF rats: a comparison to PPAR{gamma} agonism. Endocrinology 2006 147 : 4252 62.
27. Cheng L, Ding G, Qin Q et al. Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes. Biochem Biophys Res Commun 2004 313 : 277 86.
28. Kelly DP, Scarpulla RC. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev 2004 18 : 357 68.
29. Schreiber S, Knutti D, Brogli K, Uhlmann T, Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor α (ERRα). J Biol Chem 2003 278 : 9013 8.